Amrinone is a bipyridine drug with characteristic effects on the force-velocity relationship of fast skeletal muscle. Here we combined in vitro motility assays, transient biochemical kinetics and optical tweezers studies to elucidate the mechanisms underlying the drug effects. Amrinone (1-2 mM) reduced the sliding velocity of heavy meromyosin (HMM) propelled actin filaments by 31.0 5 2.5% (n ¼ 15) at different ionic strengths of the assay solution (20 -160 mM). The drug also reduced (by 2 -18%) the sliding velocity of actin filaments propelled by subfragment 1 (S1). Stopped-flow studies of myofibrils, acto-HMM and acto-S1 showed no amrinone-induced reduction in the rate of MgATP induced actomyosin dissociation and optical tweezers studies detected no changes in the working stroke length. In contrast, the ADP affinity of acto-HMM (but not acto-S1) was increased about two-fold by 1 mM amrinone. Our results are consistent with inhibition of a strain-dependent MgADP-release step as the basis for amrinone induced reduction in sliding velocity. Modeling suggests that such an effect may also account for most other amrinone-induced changes of the force-velocity relationship of muscle (e.g. in isometric force and in shape of the force-velocity curve). Moreover, the results point to the possible importance of cooperative interactions between the two myosin heads in muscle contraction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.